Phospholipase and esterase production by clinical strains of Fonsecaea pedrosoi and their interactions with epithelial cells

Mycopathologia

Volumn 170, Issue 1, 2010, Pages 31-37

  Palmeira, Vanila Faber ^a   Kneipp, Lucimar Ferreira ^b   Alviano, Celuta Sales ^a   dos Santos, André Luis Souza ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cellular interaction; Clinical strains; Differentiation; Esterase; Fonsecaea pedrosoi; Phospholipase

Indexed keywords

ESTERASE; FUNGAL PROTEIN; PHOSPHOLIPASE; VIRULENCE FACTOR;

ANIMAL; ARTICLE; ASCOMYCETES; CELL ADHESION; CELL VACUOLE; CHO CELL; CHROMOMYCOSIS; CRICETULUS; ENZYMOLOGY; EPITHELIUM CELL; HAMSTER; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

ANIMALS; ASCOMYCOTA; CELL ADHESION; CHO CELLS; CHROMOBLASTOMYCOSIS; CRICETINAE; CRICETULUS; EPITHELIAL CELLS; ESTERASES; FUNGAL PROTEINS; HUMANS; PHOSPHOLIPASES; VACUOLES; VIRULENCE FACTORS;

FONSECAEA PEDROSOI;

EID: 77953479244     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-010-9293-6     Document Type: Article

References (27)

1. Kwon-Chung KJ, Bennett JE. Chromoblastomycosis. In: Cann C, Hunsberger S, editors. Medical Mycology. Philadelphia: Lea and Febiger Inc.; 1992. p. 337-55.
2. Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infection caused by dematiaceous fungi. J Chemother. 2003; 15: 36-47.
3. Santos ALS, Palmeira VF, Rozental S, Kneipp LF, Nimrichter L, Alviano DS, et al. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis. FEMS Microbiol Rev. 2007; 31: 570-91.
4. Silva JP, De Souza W, Rozental S. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic region (Brazil). Mycophatologia. 1999; 143: 171-5.
5. Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001; 44: 585-92.
6. Kondo M, Hiruma M, Nishioka Y, Mayuzumi N, Mochida K, Ikeda S, et al. A case of chromomycosis caused by Fonsecaea pedrosoi and a review of reported cases of dematiaceous fungal infection in Japan. Mycoses. 2005; 48: 221-5.
7. Richard-Blum S, Hartmann DJ, Esterre P. Monitoring of extracellular matrix metabolism and cross-linking in tissue, serum and urine of patients with chromoblastomycosis, a chronic skin fibrosis. Eur J Clin Invest. 1998; 28: 748-54.
8. Palmeira VF, Kneipp LF, Alviano CS, Santos ALS. The major chromoblastomycosis fungal pathogen Fonsecaea pedrosoi extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures. FEMS Immunol Med Microbiol. 2006; 46: 21-9.
9. Palmeira VF, Kneipp LF, Alviano CS, Santos ALS. Secretory aspartyl peptidase from mycelia of Fonsecaea pedrosoi: effect of HIV peptidase inhibitors. Res Microbiol. 2006; 157: 819-26.
10. Palmeira VF, Kneipp LF, Rozental S, Alviano CS, Santos ALS. Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence. PLoS ONE. 2008; 3: e3382.
11. Okeke CN, Gugnani HC. Lipases of Fonsecaea pedrosoi and Phialophora verrucosa. Antonie van Leeuwenhoek. 1989; 55: 313-24.
12. Corbellini VA, Scroferneker ML, Carissimi M, Da Costa JM, Ferrão MF. Lipolytic activity of chromoblastomycosis agents measured by infrared spectroscopy and chemometric methods. Med Mycol. 2009; 47: 63-9.
13. Ghannoun MA. Potential role of phospholipase in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000; 13: 122-43.
14. Aktas E, Yigit N, Ayyldiz A. Esterase activity in various Candida species. J Int Med Res. 2002; 30: 322-4.
15. Limongi CL, Rozental S, Alviano CS, De Souza W. The influence of surface carbohydrates on the interaction of Fonsecaea pedrosoi with Chinese hamster ovary glycosylation mutant cells. Mycophatologia. 1997; 138: 127-35.
16. Wroblewski F, Ladue JS. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955; 90: 210-3.
17. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982; 15: 179-85.
18. Schoofs A, Odds FC, Colebunders R, Leven M, Goussens H. Use of specialized isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis. 1997; 16: 296-300.
19. Ibrahim AS, Mirbod F, Filler SG, Banno Y, Cole GT, Kitajima Y, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995; 63: 1993-8.
20. Chen SC, Wright LC, Golding JC, Sorrell TC. Purification characterization of secretory phospholipase B lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J. 2000; 347: 431-9.
21. Shen DK, Noodeh AD, Kazemi A, Grillot R, Robson G, Brugère JF. Characterisation and expression of phospholipases B from the opportunistic fungus Aspergillus fumigatus. FEMS Microbiol Lett. 2004; 239: 87-93.
22. Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol. 1985; 131: 1217-21.
23. Rudek W. Esterase activity in Candida species. J Clin Microbiol. 1978; 8: 756-69.
24. Slifkin M, Cumbie R. Evaluation of the Tween 80 opacity test in the identification of dermatophytes. Med Microbiol Lett. 1996; 5: 401-7.
25. Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol. 2000; 38: 4626-8.
26. Kumar CP, Menon T, Sundararajan T, Nalini S, Thirunarayan MA, Rajasekaran S, et al. Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol. 2006; 23: 101-3.
27. Kneipp LF, Palmeira VF, Pinheiro AAS, Alviano CS, Rozental S, Travassos LR, et al. Phosphatase activity on the cell wall of Fonsecaea pedrosoi. Med Mycol. 2003; 41: 469-77.